|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Pharmakon Advisors LP
✚
|
|
|---|---|
| CRD # | 161150 |
| SEC # | 801-74263 |
| CIK # | |
| AUM | $2.9 B (2025-04-11) |
| Employees | 13 (62% Investors, 0% Brokers) |
| Phone | 212-883-2296 |
| Address | 110 East 59th Street New York, NY 10022-1304 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Biopharma Credit Investments V Master LP | [2020-03-27] | 12.5 | 1,706.7 |
| PE | Pharmakon Opportunities LP | 2019-03-29 | 46.5 | |
| PE | Biopharma Secured Investments III Cayman Feeder LP | 2018-03-29 | 5.4 | |
| PE | Biopharma Secured Investments III Holdings Cayman LP | 2018-03-29 | 16.7 | |
| PE | Biopharma Secured Investments III Partners LP | 2018-03-29 | 11.8 | |
| PE | Biopharma Credit Investments IV SARL | [2016-03-29] | 0.0 | 0.0 |
| PE | Biopharma Secured Investments III SARL | [2014-03-31] | 247.8 | 344.9 |
| PE | Biopharma Secured Debt Fund LP | [2012-02-15] | 155.5 | 121.3 |
| PE | Biopharma Secured Investments II SARL | [2012-02-15] | 184.1 | 138.5 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 1.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 1.2 |
| Total | 5 | 2.9 |
| By Discretionary | ||
| Discretionary | 5 | 2.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 2.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.6 | |
| United States Persons | 1.3 | |
| Total | 5 | 2.9 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 | |
|---|---|---|---|---|
| Hugo Froment | 7 | |||
| Benjamin Schliemann | 5 | |||
| Martin Galliver | 4 | |||
| Pedro Gonzalez de Cosio | 5 | |||
| David Catala | 5 | |||
| Biopharma Credit Investments V GP LLC | 3 | |||
| Pierre Claudel | 2 | |||
| Andrew Oshea | 2 | |||
| Pablo Legoretta | 2 | |||
| Miroslava Jassova | 1 | |||
| View All | ||||
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Vance Street Management LLC
✚
|
CA | 3.0 |
|
Tomales Bay Capital LP
✚
|
3.0 | |
|
Kingswood Capital Management LP
✚
|
CA | 2.9 |
|
SCI Capital Partners LP
✚
|
CA | 2.9 |
|
Anthos Management LP
✚
|
CA | 2.9 |
|
CR Group LP
✚
|
TX | 2.9 |
|
Yellow Wood Partners LLC
✚
|
MA | 2.9 |
|
Popular Asset Management LLC
✚
|
PR | 2.9 |
|
Calera Capital Advisors LP
✚
|
CA | 2.9 |
|
Ampersand Management LLC
✚
|
MA | 2.8 |